Clinical Trial Update: An Efficacy and Safety Study of LTG-001 Following Abdominoplasty [Phase 2]

View source ↗

Summary

Latigo Biotherapeutics reports completion of a Phase 2 trial evaluating LTG-001 for efficacy and safety in acute postoperative pain after abdominoplasty.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain
• Postoperative Pain

Drugs mentioned

• LTG-001 (LTG-001)

Snippet

Sponsor: Latigo Biotherapeutics | Conditions: Acute Pain, Postoperative Pain Control | Phase 2 | Status: COMPLETED